首药控股筹划境外发行股份（H股）并在香港联交所上市

Core Viewpoint - The company, Shouyao Holdings (688197), is planning to issue overseas shares (H-shares) and list on the Hong Kong Stock Exchange to enhance its core competitiveness and brand influence, while optimizing its capital structure and diversifying financing channels [1] Group 1 - The company is currently in discussions with intermediaries regarding the specific progress of the H-share listing [1] - The details of the H-share listing have not yet been finalized [1] - The H-share listing will not result in any changes to the company's controlling shareholder or actual controller [1]